iRadimed
IRMD
19 hedge funds and large institutions have $17.1M invested in iRadimed in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
77% more capital invested
Capital invested by funds: $9.62M → $17.1M (+$7.45M)
12% more funds holding
Funds holding: 17 → 19 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
+$402K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$137K |
| 3 |
Stifel Financial
St. Louis,
Missouri
|
+$114K |
| 4 |
GMCM
Gruber & McBaine Capital Management
San Francisco,
California
|
+$48.4K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$25.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$432K |
| 2 |
SC
Sophrosyne Capital
New York
|
-$254K |
| 3 |
RA
Royce & Associates
New York
|
-$254K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$81.8K |
| 5 |
Goldman Sachs
New York
|
-$40.6K |
IRMD Hedge Fund Activity: Q4 2014 in Review
19 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q4 2014, worth a combined $17.1M — up 77% from $9.62M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new IRMD positions and 2 closed out — a net gain of 4 holders — while 5 added to existing stakes and 5 trimmed.
The largest buyer was Northpointe Capital, opening a new position worth an estimated $402K. The largest seller was Broadfin Capital, cutting an estimated $432K.
- 19 institutional investors held iRadimed (IRMD) as of Q4 2014, up from 17 in Q3 2014.
- Funds reported $17.1M of iRadimed stock for Q4 2014, up 77% quarter-over-quarter.
- 6 funds opened new iRadimed positions in Q4 2014 and 2 closed out, a net change of +4 holders.
- The largest iRadimed buyer in Q4 2014 was Northpointe Capital, an estimated $402K added.
- The largest iRadimed seller in Q4 2014 was Broadfin Capital, an estimated $432K sold.
Based on aggregated 13F filings for Q4 2014.